Milliken & Company
February 7, 2007
Hon. Charles B. Rangel
Chairman
Committee on Ways and Means
U.S. House of Representatives
1102 Longworth House Office Building
Washington, DC 20515
Dear Chairman Rangel:
On behalf of
Milliken & Company, these comments are submitted in response to the
Advisory from the Committee on Ways and Means, dated January 31, 2007,
requesting comments from the public on what action, if any, the Committee
should take with respect to the modification the Department of Commerce
(“Commerce”) has proposed to its calculation of weighted average dumping
margins in investigations.
Milliken &
Company is located in Spartanburg, South Carolina, and is one of the largest
privately held textile and chemical manufacturers in the world. Milliken
is an international leader in research technology, innovation, and customer
service. Milliken’s rich history of technological innovation has resulted
in more than 2,000 patents and the development of the largest textile research
center in the world.
We urge the
Committee to oppose the modification to our trade remedy laws proposed by
Commerce. Commerce’s change will potentially reduce or eliminate
dumping margins in many cases and thus deny domestic producers needed relief
from unfair trade. The modification proposed by Commerce would abandon
longstanding policy by eliminating “zeroing” in average to average comparisons
in antidumping investigations. The proposed approach would fail to
capture one hundred percent of dumping identified in the calculation of the
dumping margin, which could expose domestic producers to unfair import
competition without recourse to adequate relief under our trade remedy laws.
The Committee
should ask Commerce to withdraw the proposed change, and the Committee should
vote under Section 123(g)(3) of the Uruguay Round Agreements Act (19 U.S.C. §
3533(g)(3)) to signal its opposition to the proposed modification.
Instead of implementing the modification as proposed, Commerce should pursue
clarification of U.S. rights through negotiations at the WTO. Finally,
Milliken & Company urges the Committee to take all necessary steps to
ensure that U.S. trade remedy laws are not weakened through the implementation
of erroneous and overreaching decisions of WTO dispute settlement panels and
the Appellate Body.
The WTO’s
decisions on “zeroing” have created obligations for the U.S. that are not found in the text of the WTO Agreements. The U.S. government has recognized
this problem, and it called the WTO decision Commerce is proposing to implement
“deeply flawed.” When WTO panels and the Appellate Body violate the rules
of the WTO Agreement by issuing decisions that exceed their authority, the U.S.
should work to preserve the balance of rights and obligations it agreed
to by seeking a negotiated solution that reaffirms the rights of the U.S. at
the WTO. The United States should also work to fix dispute settlement
rules to stop overreaching by WTO panels and the Appellate Body, particularly
in the trade remedy area.
Congress has
also identified WTO overreaching as a serious concern, pointing in particular
to the issue of “zeroing.” Commerce should not be rushing to implement a
WTO decision that both the Administration and Congress find to be fundamentally
flawed. Instead, the U.S. should ensure that U.S. rights are honored in
WTO disputes and that the full strength and effectiveness of our domestic trade
remedy laws is preserved.
Milliken &
Company urges the Committee to vigorously oppose the change proposed by
Commerce. Instead, Congress should require Commerce to continue its
long-standing practice of capturing one hundred percent of dumping when
calculating dumping margins in investigations and the United States should continue to pursue clarification of U.S. rights through negotiations at the
WTO.
We appreciate
the Committee’s attention to this important issue, and are grateful for the
opportunity to provide these comments.
Respectfully
submitted,
John F. Nash
Jr.
Washington Counsel |